BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20674827)

  • 1. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.
    Esteitie R; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):155-61. PubMed ID: 20674827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
    Martin BG; Andrews CP; van Bavel JH; Hampel FC; Klein KC; Prillaman BA; Faris MA; Philpot EE
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
    Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
    Nathan RA; Berger W; Yang W; Cheema A; Silvey M; Wu W; Philpot E
    Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.
    Saengpanich S; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
    Cingi C; Ozlugedik S
    Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.
    Banov CH; Woehler TR; LaForce CF; Pearlman DS; Blumenthal MN; Morgan WF; Frazer H; Southern DL; Gold B; Field E
    Ann Allergy; 1994 Sep; 73(3):240-6. PubMed ID: 8092559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
    Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
    Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
    Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
    Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
    Lu S; Malice MP; Dass SB; Reiss TF
    J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis.
    Potter PC; Van Niekerk CH; Schoeman HS
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):368-74. PubMed ID: 14582816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
    Goh BS; Ismail MI; Husain S
    J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.